[#item_full_content] MMJ International Holdings, a pharmaceutical company developing cannabinoid therapies, has filed a federal lawsuit challenging the Centers for Medicare & Medicaid Services’ (CMS) newly launched Substance Access Beneficiary Engagement Incentive (BEI) program. The lawsuit alleges CMS created a federally supported cannabinoid access pathway for Medicare beneficiaries without required rulemaking, public notice, or FDA clinical validation standards, raising concerns over regulatory overreach and patient safety. 
Read More
